Financials
- Market Capitalization 36.38 M
- Employee 12
- Founded 2001
- CEO Joel Latham
- Website www.incannex.com.au
- Headquarter Delaware, United States
- FIGI BBG01J0814Y2
- Industry Case Farmaceutiche - Specialistico e Generico
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.27
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4133 | INCR Intercure Ltd. - ordinary shares | 4.95 USD | 0.00% | -6.95% | -3.32% | +203.68% | 54.13 M USD | ||
| 4256 | SCYX SCYNEXIS, Inc. - Common Stock | 4.03 USD | -1.23% | -20.98% | -16.91% | +391.46% | 40.10 M USD | ||
| 4297 | CPHI China Pharma Holdings, Inc. Common Stock | 0.84 USD | -2.33% | +27.27% | +7.69% | +27.06% | 36.14 M USD | ||
| 4361 | RMTI Rockwell Medical, Inc. - Common Stock | 7.64 USD | -3.17% | -4.74% | -3.90% | +570.18% | 30.79 M USD |